𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients

✍ Scribed by Joanne L. Blum; Véronique Dieras; Patricia Mucci Lo Russo; John Horton; Olga Rutman; Aman Buzdar; Bruno Osterwalder

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
126 KB
Volume
92
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of vinorelbine administer
Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma
✍ Nuhad K. Ibrahim; Zia Rahman; Vicente Valero; Jie Willey; Richard L. Theriault; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## BACKGROUND. Vinorelbine given by weekly bolus injection is active and less toxic than bolus vinblastine in the treatment of patients with metastatic breast carcinoma. Vinblastine given by 5-day continuous infusion showed a steep doseresponse curve. Pharmacokinetic studies of vinorelbine showed

Oral estramustine and cyclophosphamide i
Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma : A phase II study
✍ Sergio Bracarda; Maurizio Tonato; Paolo Rosi; Verena De Angelis; Ettore Mearini; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## BACKGROUND. Nearly all cases of metastatic prostate carcinoma progress, after hormonal ablation, to a hormone refractory status. To the authors' knowledge no standard chemotherapy for patients with hormone refractory prostate carcinoma (HRPC) exists. In a prospective study, the efficacy and toxi